{"id":999,"date":"2026-04-24T20:52:50","date_gmt":"2026-04-24T20:52:50","guid":{"rendered":"https:\/\/nueva.genolifeadn.com\/?page_id=999"},"modified":"2026-05-05T21:59:35","modified_gmt":"2026-05-05T21:59:35","slug":"secuenciacion-de-brca1-y-brca2","status":"publish","type":"page","link":"https:\/\/nueva.genolifeadn.com\/en\/secuenciacion-de-brca1-y-brca2\/","title":{"rendered":"BRCA1 and BRCA2 sequencing"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\nAm I predisposed to breast cancer?\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Breast cancer is the second leading cause of cancer death in women worldwide, second only to lung cancer. If we put it into a simple statistic, 1 in 39 women will die from this condition.<\/p>

This type of cancer usually occurs at early ages due to some genetic mutations. The main ones are in the BRCA1 and BRCA2 genes.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tImportance of BRCA1 and BRCA2 genes\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Genes\u00a0BRCA1<\/strong>\u00a0(BReast CAncer 1)\u00a0<\/em>y\u00a0BRCA2<\/strong>\u00a0(BReast CAncer 2)\u00a0<\/em>are considered tumor suppressor genes. They are responsible for the production of proteins of great importance in the\u00a0DNA repair.<\/strong>\u00a0When there is any\u00a0failure<\/strong>\u00a0o\u00a0mutation<\/strong>\u00a0in any of\u00a0these genes<\/strong>, As a result, the natural repair process is altered and general mutations accumulate throughout our DNA. This causes the\u00a0cells<\/strong>\u00a0do not behave<\/strong>\u00a0as they should, and eventually triggers what we know as the\u00a0cancer cells<\/strong>. Mutations in these genes have also been shown to promote the development of ovarian cancer and prostate cancer in men. At the present time\u00a0there are therapies<\/strong>\u00a0that function better depending on whether certain mutations exist in these genes or not. This makes our\u00a0forecast<\/strong>\u00a0improve significantly, in the case of\u00a0already suffering from a tumor.<\/strong><\/p>

At GENOLIFE we recommend the sequencing study of the BRCA1 and BRCA2 genes, especially in cases where several family members have already had breast or ovarian cancer. Knowing in time can help us to prevent and take measures.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tStudy details\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The study for BRCA1 and BRCA2 gene sequencing is very simple. The sample is a buccal exudate (which is done with a totally painless swab) or with blood. It will depend on the preferences of each individual, since the reliability is the same. The result of the study, by its nature, usually has a delivery period of 60 working days.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
\n
\n

BRCA1 and BRCA2 sequencing<\/h2>\n <\/div>\n
\n $<\/span><\/span><\/span><\/span> <\/div>\n
\n